East & Concord Partners

Follow

Issues to note when a parent absorbs a wholly owned subsidiary by merger

October 6 2015 There are a number of methods that a merger and restructuring may take, such as equity transfer, asset transfer, investing in other enterprises…

母公司吸收合并全资子公司的注意问题

October 6 2015 兼并重组包括多种方式,如股权或资 产的转让、以增资方式对其他企业 进行投资、企业之间的合并分立等。本文 将介绍母公司吸收合并全资子公司应该关 注的几个法律问题。文中所指公司为有限 责任公司。 母公司注册资本 从表面上看,公司合并似乎是合并方与 被合并方之间的关系,但实质上却是股东…

美国法律的域外适用和影响

July 5 2019 近年来,美国法律在全球的影响力越来越大,管辖范围越来越广,对美国域外的交易和交易主体都产生了重大影响…

Using valuation adjustment mechanisms in M&A deals

October 6 2015 Valuation adjustment mechanisms, or VAM agreements, have been employed in mergers and acquisition deals. VAM agreements were first used in private…

民事诉讼中的律师调查令

July 15 2019 资讯律师调查令在民事诉讼程序中运用的法律依据主要来自于《民事诉讼法》第64条的规定:“当事人及其诉讼代理人因…

Snapshot: medicine and medical device pricing in China

November 30 2021 A brief look at some of the key issues surrounding the pricing of medicinal products and medical devices in China.

In brief: digital healthcare in China

November 30 2021 A look at some of the key issues surrounding the digitisation of the healthcare sector in China, including data protection and privacy concerns.

Q&A: the promotion and sale of pharmaceuticals and medical devices in China

October 20 2021 This Q&A covers the essential legal and practical considerations surrounding the promotion and sale of pharmaceuticals and medical devices in China.

Q&A: marketing authorisation for pharmaceuticals and medical devices in China

October 20 2021 This article answers some of the key legal and practical questions surrounding the grant of marketing authorisation for pharmaceuticals and medical devices in China.

In brief: regulation of healthcare M&A in China

June 30 2021 This article highlights the key legal and regulatory issues surrounding healthcare M&A in China, including merger control and required consents, notifications and filings.